Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ice cream as medicine? study tests sweet treat for fatty liver and diabetes

NCT ID NCT06724913

Ongoing Disease control Sponsor: Federal State Budgetary Scientific Institution Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether special ice creams made with natural sweeteners (brazzein, maltitol, erythritol, and fibers) can help control blood sugar and be easier on digestion than regular ice cream. One hundred adults with non-alcoholic fatty liver disease and type 2 diabetes will try three different ice creams on separate days. Researchers will monitor blood sugar continuously and ask about bowel habits to see which ice cream is best tolerated.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
special ice cream with brazzein, maltitol, oligofructose, erythritol, and inulin
What this could lead to
If it works, this could point toward a tasty, diet-friendly option to help manage blood sugar in people with fatty liver and diabetes.
What could go wrong
This is a very small, early study (100 people) testing ice cream over just 3 days. It only looks at short-term blood sugar and digestion, not long-term health or disease reversal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS TYPE 2 (T2DM) NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Contacts and locations

Locations

  • Dpt Gastroenterology, Hepatology and Nutrition, Federal Research Centre of Nutrition and Biotechnology, Kashirskoye shosse, bld 21, Moscow, Russia.

    Moscow, 115446, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.